Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$4.17 +3.54%

+$0.17 today

Market cap
$2.21B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 8.05M

Average 7.31M

CLOV Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Clover Health Investments, Corp.NASDAQ: CLOV

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin holds steady near 20.6%

Gross margin was 20.6% in Q2 FY2026, down 0.3 pp from a year earlier. On a trailing-twelve-month basis it was 18.6%, down 5.3 pp year over year. Over 3 fiscal years it widened by 9.1 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
20.6%-0.7 pp QoQ
Last fiscal yearDec 2025
18.5%-8.1 pp YoY
LTMJun 2026
18.6%-5.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.3 pp——
1 year-8.1 pp——
3 years+9.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
18.5%
Year-over-year change
-8.1pp

Gross Margin vs competitors

How CLOV compares with its peers on the latest reported figures

  • CLOV's LTM Jun 2026 gross margin of 18.6% is the 2nd highest of the 7 companies compared; the peer median is 13.6%.
  • Its year-over-year change of -5.3 pp is the lowest of 7, against a peer median of +0.6 pp.
  • Over three fiscal years its change of +9.1 pp compares with a peer median of -3.3 pp.
CLOV Competitors Peer median
Gross Margin for CLOV and competitors
Company Period LTM level YoY 3-year change
OSCROscar Health, Inc.LTM Jun 202644.9% +9.0 pp-85.6 pp
CLOVClover Health Investments, Corp.LTM Jun 202618.6% -5.3 pp+9.1 pp
CNCCentene CorporationLTM Jun 202616.1% +7.2 pp+0.7 pp
CVSCVS Health CorporationLTM Jun 202614.2% +0.3 pp-3.1 pp
HUMHumana Inc.LTM Sep 202613.0% -1.9 pp-4.0 pp
ALHCAlignment Healthcare, Inc.LTM Mar 202612.4% +0.8 pp-0.5 pp
CICigna CorporationLTM Sep 202610.3% +0.2 pp-3.6 pp
Peer median (excluding CLOV) 13.6%+0.6 pp-3.3 pp

Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.47B1.1B1.26B1.37B1.92B
Cost of Revenue1.55B993.07M1B1.01B1.57B
Gross Profit(79.18M)103.48M255.95M364.8M355.88M
Gross Margin-5.4%9.4%20.3%26.6%18.5%
Research & Development00000
Selling, General & Admin445.75M482.4M440.25M408.93M176.32M
Operating Expenses557.81M390.14M461.28M410.55M441.43M
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
EBITDA(569.6M)(252.03M)(207.63M)(44.94M)(83.86M)
EBITDA Margin-38.7%-23.0%-16.5%-3.3%-4.4%
Operating Income(636.99M)(286.66M)(205.33M)(45.75M)(85.53M)
Operating Margin-43.3%-26.1%-16.3%-3.3%-4.4%
Interest Income00000
Interest Expense16.91M1.36M7K00
Other Income / Expenses49.24M32.08M(4.82M)(517K)(20K)
Income Before Tax(587.76M)(254.58M)(210.15M)(46.27M)(85.55M)
Pre-Tax Margin-39.9%-23.2%-16.7%-3.4%-4.4%
Income Tax Expense00000
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Net Margin-39.9%-31.0%-16.9%-3.1%-4.4%
EPS (Basic)(1.25)(0.71)(0.45)(0.09)(0.17)
EPS (Diluted)(1.25)(0.71)(0.45)(0.09)(0.17)
Weighted Avg Shares470.85M476.24M482.18M490.02M517.24M
Weighted Avg Shares (Diluted)470.85M476.24M482.18M490.02M517.24M

Clover Health Investments, Corp.

NASDAQ:CLOV

Intrinsic Alpha fair value

Locked

Current Price

$4.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.